THAR logo

Tharimmune (THAR)

Profile

Full Name

Tharimmune, Inc.

Ticker Symbol

THAR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 12, 2022

Indexes

Not included

Website

http://www.tharimmune.com

Employees

2

Key Details

Price

$1.15(-2.13%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$9.41(+91.21% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.15
THAR price is $1.15

30-Day Relative Volume

0.10
THAR 30-day relative volume is 0.10

Price Performance

Price Most recent change

-2.13%
THAR price was down -2.13% on Apr 15, 2025

Price YTD change

-43.35%
THAR price is down -43.35% since January 1st

Price 1-year change

-79.17%
THAR price is down -79.17% year-on-year

Price 3-year change

-99.78%
THAR price is down -99.78% over the past 3 years

Price Range

Price All-time high

$1590.00
THAR price is currently -99.93% below its historical high of $1590.00

Price 3-year low

$0.95
THAR price is currently +20.80% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.43M
THAR market capitalization is $2.43 million

Market cap 3-year change

-84.86%
THAR market capitalization is down -84.86% over the past 3 years

Market cap All-time high

$46.13M
THAR market capitalization is currently -94.74% below its historical high of $46.13 million

Market cap sector rank

7.48%
THAR market capitalization is higher than 7.48% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+168.3%
THAR shares outstanding is up +168.3% year-on-year

Shares Outstanding 3-Year Change

+6859.74%
THAR shares outstanding is up +6859.74% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.60
THAR beta is 0.60

200-day SMA

$2.32
THAR price is currently -50.51% below its 200-day simple moving average

50-day SMA

$1.52
THAR price is currently -24.54% below its 50-day simple moving average

RSI

36.61
THAR 14-day relative strength index is 36.61

Volume

0.10
THAR 30-day relative volume is 0.10

ATR

$0.13
THAR average true range is $0.13

10-day Historical Volatility

72.04%
THAR 10-day historical volatility is 72.04%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
THAR annual revenue value is unknown

Revenue Analysts estimate

-
THAR annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
THAR annual revenue 1-year change is unknown

Revenue Sector rank

-
THAR annual revenue is unknown

EPS

EPS

-$9.41
THAR annual earnings per share is -$9.41

EPS Analysts estimate

-$0.12
THAR annual earnings per share is currently +7741.67% higher than the consensus analysts' forecast

EPS 1-year change

+91.21%
THAR annual earnings per share is up +91.21% year-on-year

EPS Sector rank

12.51%
THAR annual earnings per share is higher than 12.51% of companies in Healthcare sector

Profit

Gross profit

-
THAR annual gross profit value is unknown

Gross margin

-
THAR annual gross profit margin value is unknown

Operating profit

-$12.43M
THAR annual operating income is -$12.43 million

Operating margin

-
THAR annual operating profit margin value is unknown

Net income

-$12.20M
THAR annual net profit is -$12.20 million

Net margin

-
THAR annual net profit margin value is unknown

Expenses

Total expenses

$12.43M
THAR annual total expenses is $12.43 million

Operating expenses

$12.43M
THAR annual total operating expenses is $12.43 million

Cost of goods sold

-
THAR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$6.04M
THAR annual SGA is $6.04 million

Depreciation and amortization

-
THAR annual depreciation & amortization value is unknown

Interest expense

$13.70K
THAR annual interest expense is $13.70 thousand

Income tax

-
THAR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$12.18M
THAR annual earnings before interest & taxes is -$12.18 million

EBITDA

-$12.18M
THAR annual EBITDA is -$12.18 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.72M
THAR annual total assets is $3.72 million

Non current assets

$0.00
THAR annual long term assets is $0.00

Current assets

$3.72M
THAR annual total current assets is $3.72 million

Cash and cash equivalents

$3.56M
THAR annual cash & cash equivalents is $3.56 million

Accounts receivable

-
THAR annual accounts receivable value is unknown

Inventory

-
THAR annual inventory value is unknown

Liabilities

Total liabilities

$2.41M
THAR annual total liabilities is $2.41 million

Long term liabilities

$0.00
THAR annual total long term liabilities is $0.00

Current liabilities

$2.41M
THAR annual total current liabilities is $2.41 million

Accounts payable

$1.09M
THAR annual accounts payable is $1.09 million

Debt

Total debt

$0.00
THAR annual total debt is $0.00

Total debt 1-year change

0%
THAR {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
THAR annual long term debt value is unknown

Short term debt

-
THAR annual short term debt value is unknown

Equity & Capital

Shareholders equity

$1.31M
THAR annual stockholders equity is $1.31 million

Book value

$1.31M
THAR annual book value is $1.31 million

Retained earnings

-$36.90M
THAR annual retained earnings is -$36.90 million

Working capital

$1.31M
THAR annual working capital is $1.31 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$10.90M
THAR annual cash flow from operations is -$10.90 million

Cash from operations 1-year change

-49.34%
THAR annual cash flow from operations is down -49.34% year-on-year

Cash from investing

$0.00
THAR annual cash flow from investing activities is $0.00

Cash from investing 1-year change

0%
THAR {parameterFullLabel} has remained unchanged year-on-year

Cash from financing

$3.53M
THAR annual cash flow from financing activities is $3.53 million

Cash from financing 1-year change

-69.93%
THAR annual cash flow from financing activities is down -69.93% year-on-year

CAPEX

CAPEX

-
THAR annual capital expenditures value is unknown

CAPEX 1-year change

-
THAR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$10.90M
THAR annual free cash flow is -$10.90 million

Free cash flow 1-year change

-49.34%
THAR annual free cash flow is down -49.34% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
THAR annual gross profit margin value is unknown

Operating margin

-
THAR annual operating profit margin value is unknown

Net margin

-
THAR annual net profit margin value is unknown

ROA & ROE

ROA

-327.75%
THAR annual return on assets is -327.75%

ROE

-932.82%
THAR annual return on equity is -932.82%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
THAR price to earnings ratio value is unknown

PE ratio Sector rank

-
THAR price to earnings ratio is unknown

PB Ratio

PB ratio

1.85
THAR price to book ratio is 1.85

PB ratio Sector rank

60.74%
THAR price to book ratio is higher than 60.74% of companies in Healthcare sector

PS Ratio

PS ratio

-
THAR price to sales ratio value is unknown

PS ratio Sector rank

-
THAR price to sales ratio is unknown

Enterprise value

Enterprise value

-$1.13M
THAR enterprise value is -$1.13 million

Enterprise value Sector rank

9.68%
THAR enterprise value is higher than 9.68% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.09
THAR EV/EBITDA is 0.09

EV/EBITDA Sector rank

66.75%
THAR EV/EBITDA is higher than 66.75% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.54
THAR annual current ratio is 1.54

Quick ratio

-
THAR annual quick ratio value is unknown

Leverage

Debt to equity

0.00
THAR annual debt to equity ratio is 0.00

Interest coverage ratio

-889.34
THAR annual interest coverage ratio is -889.34

Risk & Stability

Piotroski F-Score

-
THAR piotroski f-score value is unknown

Altman Z-Score

-
THAR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 6, 24 Rodman & Renshaw
Buy
Jul 17, 23 Dawson James
Neutral

Institutional Ownership

Similar stocks

QLGN logo
Qualigen Therapeutics (QLGN)
Syra Health Corp Class A (SYRA)
AIM logo
AIM ImmunoTech (AIM)
ENVB logo
Enveric Biosciences (ENVB)
BBLG logo
Bone Biologics (BBLG)
EYEN logo
Eyenovia (EYEN)
TIVC logo
Tivic Health Systems (TIVC)
VCNX logo
Vaccinex (VCNX)
EIGR logo
Eiger BioPharmaceuticals (EIGR)
  • What is the ticker symbol for Tharimmune?
  • Does Tharimmune pay dividends?
  • What sector is Tharimmune in?
  • What industry is Tharimmune in?
  • What country is Tharimmune based in?
  • When did Tharimmune go public?
  • Is Tharimmune in the S&P 500?
  • Is Tharimmune in the NASDAQ 100?
  • Is Tharimmune in the Dow Jones?
  • When was Tharimmune's last earnings report?
  • When does Tharimmune report earnings?
  • Should I buy Tharimmune stock now?

What is the ticker symbol for Tharimmune?

The ticker symbol for Tharimmune is NASDAQ:THAR

Does Tharimmune pay dividends?

No, Tharimmune does not pay dividends

What sector is Tharimmune in?

Tharimmune is in the Healthcare sector

What industry is Tharimmune in?

Tharimmune is in the Biotechnology industry

What country is Tharimmune based in?

Tharimmune is headquartered in United States

When did Tharimmune go public?

Tharimmune's initial public offering (IPO) was on January 12, 2022

Is Tharimmune in the S&P 500?

No, Tharimmune is not included in the S&P 500 index

Is Tharimmune in the NASDAQ 100?

No, Tharimmune is not included in the NASDAQ 100 index

Is Tharimmune in the Dow Jones?

No, Tharimmune is not included in the Dow Jones index

When was Tharimmune's last earnings report?

Tharimmune's most recent earnings report was on Nov 7, 2024

When does Tharimmune report earnings?

The next expected earnings date for Tharimmune is May 9, 2025

Should I buy Tharimmune stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page